nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—saliva—attention deficit hyperactivity disorder	0.159	0.202	CbGeAlD
Ticlopidine—P2RY12—forebrain—attention deficit hyperactivity disorder	0.0867	0.11	CbGeAlD
Ticlopidine—P2RY12—cardiovascular system—attention deficit hyperactivity disorder	0.0733	0.0927	CbGeAlD
Ticlopidine—P2RY12—nervous system—attention deficit hyperactivity disorder	0.047	0.0595	CbGeAlD
Ticlopidine—P2RY12—central nervous system—attention deficit hyperactivity disorder	0.0453	0.0573	CbGeAlD
Ticlopidine—MPO—forebrain—attention deficit hyperactivity disorder	0.038	0.0481	CbGeAlD
Ticlopidine—P2RY12—brain—attention deficit hyperactivity disorder	0.036	0.0455	CbGeAlD
Ticlopidine—MPO—cardiovascular system—attention deficit hyperactivity disorder	0.0321	0.0407	CbGeAlD
Ticlopidine—MPO—nervous system—attention deficit hyperactivity disorder	0.0206	0.0261	CbGeAlD
Ticlopidine—MPO—central nervous system—attention deficit hyperactivity disorder	0.0199	0.0251	CbGeAlD
Ticlopidine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.0169	0.0213	CbGeAlD
Ticlopidine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0167	0.0211	CbGeAlD
Ticlopidine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.0158	0.02	CbGeAlD
Ticlopidine—MPO—brain—attention deficit hyperactivity disorder	0.0158	0.02	CbGeAlD
Ticlopidine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0148	0.0188	CbGeAlD
Ticlopidine—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.0111	0.0141	CbGeAlD
Ticlopidine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.0108	0.0137	CbGeAlD
Ticlopidine—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.0107	0.0136	CbGeAlD
Ticlopidine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.0104	0.0132	CbGeAlD
Ticlopidine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.0102	0.0129	CbGeAlD
Ticlopidine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00979	0.0124	CbGeAlD
Ticlopidine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00956	0.0121	CbGeAlD
Ticlopidine—CYP2C8—brain—attention deficit hyperactivity disorder	0.00923	0.0117	CbGeAlD
Ticlopidine—CYP1A1—brain—attention deficit hyperactivity disorder	0.00852	0.0108	CbGeAlD
Ticlopidine—CYP2B6—brain—attention deficit hyperactivity disorder	0.00828	0.0105	CbGeAlD
Ticlopidine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00818	0.0103	CbGeAlD
Ticlopidine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00805	0.0102	CbGeAlD
Ticlopidine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00787	0.00996	CbGeAlD
Ticlopidine—CYP2E1—brain—attention deficit hyperactivity disorder	0.00777	0.00983	CbGeAlD
Ticlopidine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00775	0.0098	CbGeAlD
Ticlopidine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00757	0.00958	CbGeAlD
Ticlopidine—P2RY12—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0069	0.0329	CbGpPWpGaD
Ticlopidine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00615	0.00778	CbGeAlD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00486	0.0232	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00463	0.0221	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0043	0.0205	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00421	0.0201	CbGpPWpGaD
Ticlopidine—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.0042	0.02	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00418	0.0199	CbGpPWpGaD
Ticlopidine—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00412	0.0196	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00368	0.0176	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00361	0.0172	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00314	0.015	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00292	0.0139	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0028	0.0134	CbGpPWpGaD
Ticlopidine—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00279	0.0133	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00275	0.0131	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00275	0.0131	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00272	0.013	CbGpPWpGaD
Ticlopidine—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00262	0.0125	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00255	0.0122	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00255	0.0122	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00251	0.012	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0025	0.0119	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00247	0.0118	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00243	0.0116	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0024	0.0115	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00237	0.0113	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00236	0.0113	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0023	0.011	CbGpPWpGaD
Ticlopidine—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00228	0.0109	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00226	0.0108	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00224	0.0107	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00223	0.0106	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00218	0.0104	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00214	0.0102	CbGpPWpGaD
Ticlopidine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0021	0.01	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00208	0.00991	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00203	0.00969	CbGpPWpGaD
Ticlopidine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00203	0.00967	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00197	0.00939	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00193	0.00923	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00191	0.00911	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0019	0.00908	CbGpPWpGaD
Ticlopidine—MPO—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00179	0.00852	CbGpPWpGaD
Ticlopidine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00178	0.00849	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00178	0.00849	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00166	0.00794	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00756	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00155	0.0074	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00155	0.00738	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0015	0.00715	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00147	0.00703	CbGpPWpGaD
Ticlopidine—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00145	0.00694	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00145	0.00694	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00144	0.00686	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00141	0.00672	CbGpPWpGaD
Ticlopidine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00137	0.00654	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00135	0.00646	CbGpPWpGaD
Ticlopidine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00134	0.0064	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.00628	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00127	0.00605	CbGpPWpGaD
Ticlopidine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00126	0.00604	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00125	0.00595	CbGpPWpGaD
Ticlopidine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00116	0.00553	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00108	0.00513	CbGpPWpGaD
Ticlopidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00103	0.00494	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000989	0.00472	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000977	0.00466	CbGpPWpGaD
Ticlopidine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000952	0.00454	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000949	0.00453	CbGpPWpGaD
Ticlopidine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000944	0.0045	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00094	0.00449	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000874	0.00417	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000854	0.00407	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00085	0.00405	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000846	0.00404	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000833	0.00398	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000833	0.00398	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000832	0.00397	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000832	0.00397	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000822	0.00392	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000816	0.0039	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000806	0.00385	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000794	0.00379	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000769	0.00367	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000765	0.00365	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000755	0.00361	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000746	0.00356	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000737	0.00352	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000733	0.0035	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000727	0.00347	CbGpPWpGaD
Ticlopidine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000723	0.00345	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000718	0.00342	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000713	0.0034	CbGpPWpGaD
Ticlopidine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000708	0.00338	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000695	0.00332	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000677	0.00323	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000672	0.00321	CbGpPWpGaD
Ticlopidine—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000667	0.00318	CbGpPWpGaD
Ticlopidine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000622	0.00297	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00062	0.00296	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000616	0.00294	CbGpPWpGaD
Ticlopidine—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000612	0.00292	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000577	0.00275	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000554	0.00264	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00055	0.00262	CbGpPWpGaD
Ticlopidine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000546	0.00261	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000536	0.00256	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000531	0.00254	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000531	0.00254	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000509	0.00243	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000506	0.00241	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000505	0.00241	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000504	0.00241	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000502	0.0024	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000501	0.00239	CbGpPWpGaD
Ticlopidine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000498	0.00238	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000487	0.00232	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000469	0.00224	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000454	0.00217	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000449	0.00214	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000446	0.00213	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000441	0.0021	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000431	0.00206	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000428	0.00204	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000425	0.00203	CbGpPWpGaD
Ticlopidine—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000415	0.00198	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000411	0.00196	CbGpPWpGaD
Ticlopidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000406	0.00194	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000333	0.00159	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000331	0.00158	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000328	0.00157	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.00143	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.0014	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000288	0.00137	CbGpPWpGaD
Ticlopidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00028	0.00134	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000277	0.00132	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000254	0.00121	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000226	0.00108	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000208	0.000994	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000207	0.000987	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000207	0.000987	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000206	0.000985	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000203	0.000971	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000203	0.000967	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000203	0.000967	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000199	0.000951	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000191	0.000911	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000191	0.000911	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000189	0.000903	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000188	0.000897	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000185	0.000884	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000176	0.000842	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000175	0.000836	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000175	0.000836	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000175	0.000834	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000172	0.000822	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000165	0.000789	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000162	0.000773	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00016	0.000764	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.000751	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000156	0.000746	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000156	0.000746	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000736	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000154	0.000734	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000153	0.000729	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000152	0.000727	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000694	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000144	0.000686	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000144	0.000686	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.000682	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000142	0.00068	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000142	0.00068	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000141	0.000675	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00014	0.000669	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00014	0.000668	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000136	0.00065	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.000636	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000131	0.000627	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00013	0.000622	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000125	0.000598	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000596	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000124	0.000594	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000123	0.000586	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000122	0.000582	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000122	0.000581	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000122	0.000581	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00012	0.000572	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000568	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000116	0.000552	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000115	0.000548	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000548	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000114	0.000544	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000111	0.000532	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000111	0.000531	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.000522	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000518	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000106	0.000506	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000105	0.000503	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000102	0.000487	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.73e-05	0.000465	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	9.47e-05	0.000452	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	9.4e-05	0.000449	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.4e-05	0.000448	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.4e-05	0.000448	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.27e-05	0.000442	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.25e-05	0.000441	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.12e-05	0.000435	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.71e-05	0.000416	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.65e-05	0.000413	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.63e-05	0.000412	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.6e-05	0.00041	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.57e-05	0.000409	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.31e-05	0.000397	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.51e-05	0.000359	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	7.38e-05	0.000352	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.33e-05	0.00035	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.15e-05	0.000341	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.1e-05	0.000339	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.69e-05	0.000272	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.65e-05	0.00027	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	5.37e-05	0.000256	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	5.26e-05	0.000251	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.96e-05	0.000237	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	4.55e-05	0.000217	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	4.06e-05	0.000194	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.73e-05	0.000178	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.7e-05	0.000177	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.16e-05	0.000151	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.44e-05	0.000117	CbGpPWpGaD
